MANILA, Philippines - The Philippine American Life and General Insurance Co. (Philam Life) is introducing LifeSave, a 10-year life insurance-and-health plan-in-one that provides comprehensive protection, especially against critical illness.
The unique benefit of LifeSave is that the policy pays out or advances 100-percent of the life insurance coverage in case you are diagnosed with any of the 34 pre-identified critical illnesses, including cancer, stroke, heart attack, kidney failure, and liver cirrhosis.
Cash proceeds can be used to pay for any treatment, medication, diagnostic tests, therapy, or medical consultation needed to address any illness.
Moreover, LifeSave has a money-back guarantee where 50-percent of the total premiums paid will be returned to you if no illness claims have been made at the end of the 10-year period.
LifeSave comes in three variants – Silver, Gold, and Platinum that addresses various protection requirements. LifeSave Platinum offers the most comprehensive coverage as it also includes hospitalization benefits and additional benefits in case of accidents.
For as low as only P1,100 a month, payable over five years, Life Save gives its clients the peace of mind that comes with knowing that their family is protected from the financial stress caused by these unforeseen events.
To find out more about LifeSave, you may call Philam Life’s customer hotline at (02) 528-2000, or visit any of Philam Life’s branch offices nationwide. You may also visit www.philamlife.com for more details.
Philam Life is the largest life insurance company in the Philippines and market leader for over 60 years. It is part of the AIA Group Ltd., the largest independent publicly listed pan-Asian life insurance group in the world.
The AIA Group and its subsidiaries comprise the largest independent publicly listed pan-Asian life insurance group in the world.
It has wholly-owned main operating subsidiaries or branches in 14 markets in Asia Pacific – Hong Kong, Thailand, Singapore, Malaysia, China, Korea, the Philippines, Australia, Indonesia, Taiwan, Vietnam, New Zealand, Macau and Brunei, and a 26-percent joint venture shareholding in India.